Business · 23/09/2003Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Topical Dermatologic Use
Summary
The FDA has approved an abbreviated new animal drug application (ANADA) for a topical ointment containing nystatin, neomycin, thiostrepton, and triamcinolone acetonide, developed by Altana, Inc., for use in dogs and cats.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →